News
On the company’s Q2 earning call, Pfizer noted that the company’s guidance “absorbs the impact of the currently imposed tariffs from China, Canada and Mexico as well as pote ...
In a report released today, Steve Scala from TD Cowen maintained a Hold rating on Pfizer, with a price target of $30.00. The company’s shares closed yesterday at $23.53. Take advantage of TipRanks ...
The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...
Pfizer Inc. (NYSE:PFE) is one of the stocks in Jim Cramer’s game plan for this week. Cramer mentioned the company during the ...
One of the most appealing features of Pfizer's stock is its dividend. The payout recently yielded a hefty 7.4% -- and it's ...
Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.
HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...
Shares in the data-software company were up 7.8% Tuesday after it posted higher quarterly results and [boosted its annual ...
10h
The Manila Times on MSNPfizer raises 2025 profit forecastPFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.
The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...
BUCHAREST, ROMANIA - Media OutReach Newswire - 6 August 2025 - Pfizer Romania has been officially certified as one of the ...
Second Quarter 2025 Results Key Financial Results Revenue: US$14.7b (up 10% from 2Q 2024).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results